Biocryst Pharmaceuticals (BCRX) Current Deferred Tax Assets: 2010-2014
Historic Current Deferred Tax Assets for Biocryst Pharmaceuticals (BCRX) over the last 5 years, with Dec 2014 value amounting to $76,000.
- Biocryst Pharmaceuticals' Current Deferred Tax Assets rose 15.79% to $88,000 in Q3 2015 from the same period last year, while for Sep 2015 it was $88,000, marking a year-over-year increase of 15.79%. This contributed to the annual value of $76,000 for FY2014, which is 1.33% up from last year.
- Per Biocryst Pharmaceuticals' latest filing, its Current Deferred Tax Assets stood at $76,000 for FY2014, which was up 1.33% from $75,000 recorded in FY2013.
- In the past 5 years, Biocryst Pharmaceuticals' Current Deferred Tax Assets registered a high of $2.3 million during FY2011, and its lowest value of $75,000 during FY2013.
- For the 3-year period, Biocryst Pharmaceuticals' Current Deferred Tax Assets averaged around $187,667, with its median value being $76,000 (2014).
- Its Current Deferred Tax Assets has fluctuated over the past 5 years, first surged by 220.03% in 2011, then crashed by 82.09% in 2012.
- Biocryst Pharmaceuticals' Current Deferred Tax Assets (Yearly) stood at $719,000 in 2010, then soared by 220.03% to $2.3 million in 2011, then tumbled by 82.09% to $412,000 in 2012, then plummeted by 81.80% to $75,000 in 2013, then climbed by 1.33% to $76,000 in 2014.